pharma-话题@MedSci

#pharma#

608篇内容 | 2446人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1908715, encodeId=6c8f1908e150f, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=J Ethnopharmacol：中药通过抑制NLRP3炎症小体对缺血性脑卒中的调控, objectType=article, longId=728288, objectId=6d88e2828881, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d88e2828881, replyNumber=0, likeNumber=82, createdTime=2022-12-13, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d88e2828881, moduleTitle=J Ethnopharmacol：中药通过抑制NLRP3炎症小体对缺血性脑卒中的调控, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d88e2828881)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908706, encodeId=ce7d1908e0678, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=J Ethnopharmacol：中医药治疗慢传输型便秘的研究进展, objectType=article, longId=726623, objectId=b9e1e2662315, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9e1e2662315, replyNumber=0, likeNumber=109, createdTime=2022-08-21, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9e1e2662315, moduleTitle=J Ethnopharmacol：中医药治疗慢传输型便秘的研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b9e1e2662315)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908702, encodeId=69951908e025b, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Rhizen Pharmaceuticals AG在2022年欧洲肿瘤内科学会乳腺癌会议上公布一项进行中的Tenalisib (RP6530)治疗局部晚期或转移性乳腺癌患者II期研究的中期积极数据, objectType=article, longId=726291, objectId=eddae262914c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eddae262914c, replyNumber=0, likeNumber=96, createdTime=2023-02-14, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eddae262914c, moduleTitle=Rhizen Pharmaceuticals AG在2022年欧洲肿瘤内科学会乳腺癌会议上公布一项进行中的Tenalisib (RP6530)治疗局部晚期或转移性乳腺癌患者II期研究的中期积极数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eddae262914c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908691, encodeId=d5cd1908691a4, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle= Front Pharmacol：龙藤汤通过调节2型固有淋巴细胞促进胶原诱导关节炎小鼠滑膜炎症的消退, objectType=article, longId=301521, objectId=2b0d3015217c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b0d3015217c, replyNumber=0, likeNumber=70, createdTime=2022-03-25, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b0d3015217c, moduleTitle= Front Pharmacol：龙藤汤通过调节2型固有淋巴细胞促进胶原诱导关节炎小鼠滑膜炎症的消退, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b0d3015217c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908693, encodeId=9e1e19086933e, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Rhizen Pharmaceuticals AG在AACR 2022公布其差异化的PARP和DHODH抑制剂项目的数据, objectType=article, longId=724127, objectId=b5ebe2412785, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5ebe2412785, replyNumber=0, likeNumber=97, createdTime=2022-10-29, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5ebe2412785, moduleTitle=Rhizen Pharmaceuticals AG在AACR 2022公布其差异化的PARP和DHODH抑制剂项目的数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5ebe2412785)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908694, encodeId=14f7190869473, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Front Pharmacol：四妙勇安汤治疗糖尿病视网膜病变的网络药理学与体内结合研究, objectType=article, longId=724296, objectId=92f6e24296f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92f6e24296f3, replyNumber=0, likeNumber=72, createdTime=2022-07-02, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92f6e24296f3, moduleTitle=Front Pharmacol：四妙勇安汤治疗糖尿病视网膜病变的网络药理学与体内结合研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=92f6e24296f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908683, encodeId=d56a190868398, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=PCI Pharma Services继收购LSNE之后继续利用先进设备扩大无菌灌封专长, objectType=article, longId=295399, objectId=4490295399c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4490295399c1, replyNumber=0, likeNumber=67, createdTime=2022-08-05, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4490295399c1, moduleTitle=PCI Pharma Services继收购LSNE之后继续利用先进设备扩大无菌灌封专长, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4490295399c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908742, encodeId=39c71908e4296, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Clin Pharmacol Ther：血管紧张素转换酶抑制剂与胰岛素促泌剂同时使用与严重低血糖的风险, objectType=article, longId=739474, objectId=f928e39474c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f928e39474c7, replyNumber=0, likeNumber=92, createdTime=2023-05-03, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f928e39474c7, moduleTitle=Clin Pharmacol Ther：血管紧张素转换酶抑制剂与胰岛素促泌剂同时使用与严重低血糖的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f928e39474c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908680, encodeId=02fd190868043, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Clin Pharmacol Ther:Secukinumab治疗银屑病的创新儿科开发之路, objectType=article, longId=294274, objectId=fe2d2942e48c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe2d2942e48c, replyNumber=0, likeNumber=90, createdTime=2022-09-12, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe2d2942e48c, moduleTitle=Clin Pharmacol Ther:Secukinumab治疗银屑病的创新儿科开发之路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe2d2942e48c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908703, encodeId=a1061908e03f1, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Front Pharmacol：不同PCSK9抑制剂，哪个降脂力量更强？, objectType=article, longId=726544, objectId=1e53e265444e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e53e265444e, replyNumber=0, likeNumber=87, createdTime=2022-09-22, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e53e265444e, moduleTitle=Front Pharmacol：不同PCSK9抑制剂，哪个降脂力量更强？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e53e265444e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908746, encodeId=00851908e4688, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Rhizen Pharmaceuticals AG宣布即将在ESMO 2022上展示其临床阶段的资产数据；Tenalisib治疗局部晚期/转移性乳腺癌和RP12146治疗多种实体瘤, objectType=article, longId=739183, objectId=460ce39183f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=460ce39183f7, replyNumber=0, likeNumber=115, createdTime=2022-10-26, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=460ce39183f7, moduleTitle=Rhizen Pharmaceuticals AG宣布即将在ESMO 2022上展示其临床阶段的资产数据；Tenalisib治疗局部晚期/转移性乳腺癌和RP12146治疗多种实体瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=460ce39183f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908684, encodeId=af6e19086842a, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Eur J Clin Pharmacol：DOAC剂量处方不当在≥80岁房颤患者中的发生率和预测因素分析, objectType=article, longId=298983, objectId=2dad298983a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2dad298983a5, replyNumber=0, likeNumber=88, createdTime=2022-04-01, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2dad298983a5, moduleTitle=Eur J Clin Pharmacol：DOAC剂量处方不当在≥80岁房颤患者中的发生率和预测因素分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2dad298983a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908705, encodeId=97071908e058f, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Xlear与Dr. Ferrer BioPharma合作，向用户提供更佳鼻腔卫生体验, objectType=article, longId=727374, objectId=ef9de27374d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef9de27374d3, replyNumber=0, likeNumber=109, createdTime=2022-11-15, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef9de27374d3, moduleTitle=Xlear与Dr. Ferrer BioPharma合作，向用户提供更佳鼻腔卫生体验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ef9de27374d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908711, encodeId=c8741908e113c, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Front Pharmacol：益生菌联合中药治疗溃疡性结肠炎的疗效和安全性, objectType=article, longId=728791, objectId=250fe2879102, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=250fe2879102, replyNumber=0, likeNumber=94, createdTime=2022-12-17, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=250fe2879102, moduleTitle=Front Pharmacol：益生菌联合中药治疗溃疡性结肠炎的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=250fe2879102)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908719, encodeId=0ddc1908e194e, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Front Pharmacol：中医药治疗阿尔茨海默病合并骨质疏松症的广阔前景, objectType=article, longId=730934, objectId=3b82e309345b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b82e309345b, replyNumber=0, likeNumber=87, createdTime=2023-03-23, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b82e309345b, moduleTitle=Front Pharmacol：中医药治疗阿尔茨海默病合并骨质疏松症的广阔前景, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b82e309345b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908737, encodeId=c55e1908e3787, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Front Pharmacol：祛毒散结汤诱导NF2相关前庭神经鞘瘤生长抑制和血管正常化, objectType=article, longId=738710, objectId=073ee38710b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=073ee38710b5, replyNumber=0, likeNumber=105, createdTime=2023-04-30, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=073ee38710b5, moduleTitle=Front Pharmacol：祛毒散结汤诱导NF2相关前庭神经鞘瘤生长抑制和血管正常化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=073ee38710b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908732, encodeId=87911908e329f, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=J Ethnopharmacol：清肺口服液通过Akt信号通路促进脂肪酸依赖性M1/M2巨噬细胞极化，减轻RSV诱导的肺部炎症, objectType=article, longId=736264, objectId=e62ee36264db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e62ee36264db, replyNumber=0, likeNumber=86, createdTime=2023-06-09, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e62ee36264db, moduleTitle=J Ethnopharmacol：清肺口服液通过Akt信号通路促进脂肪酸依赖性M1/M2巨噬细胞极化，减轻RSV诱导的肺部炎症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e62ee36264db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908721, encodeId=abf21908e214a, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Front Pharmacol：具有伤口愈合特性的中药, objectType=article, longId=730957, objectId=c16de30957f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c16de30957f7, replyNumber=0, likeNumber=95, createdTime=2022-10-10, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c16de30957f7, moduleTitle=Front Pharmacol：具有伤口愈合特性的中药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c16de30957f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908679, encodeId=bb1c19086e981, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Skin Pharmacol Physiol：壳聚糖凝胶可有效减少皮肤出油, objectType=article, longId=294067, objectId=a62929406e9f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a62929406e9f, replyNumber=0, likeNumber=80, createdTime=2022-06-17, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a62929406e9f, moduleTitle=Skin Pharmacol Physiol：壳聚糖凝胶可有效减少皮肤出油, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a62929406e9f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908712, encodeId=3dc21908e12b2, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=J Ethnopharmacol：清热中药注射剂治疗AECOPD疗效比较, objectType=article, longId=728273, objectId=f05ee2827381, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f05ee2827381, replyNumber=0, likeNumber=93, createdTime=2023-02-25, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f05ee2827381, moduleTitle=J Ethnopharmacol：清热中药注射剂治疗AECOPD疗效比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f05ee2827381)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

pharma

2020-05-29

chentianping (审核中...)

前往app查看评论内容

#pharma#

J Ethnopharmacol：中药通过抑制NLRP3炎症小体对缺血性脑卒中的调控

2022-12-13

chentianping (审核中...)

前往app查看评论内容

#pharma#

J Ethnopharmacol：中医药治疗慢传输型便秘的研究进展

2022-08-21

chentianping (审核中...)

前往app查看评论内容

#pharma#

Rhizen Pharmaceuticals AG在2022年欧洲肿瘤内科学会乳腺癌会议上公布一项进行中的Tenalisib (RP6530)治疗局部晚期或转移性乳腺癌患者II期研究的中期积极数据

2023-02-14

chentianping (审核中...)

前往app查看评论内容

#pharma#

Front Pharmacol：龙藤汤通过调节2型固有淋巴细胞促进胶原诱导关节炎小鼠滑膜炎症的消退

2022-03-25

chentianping (审核中...)

前往app查看评论内容

#pharma#

Rhizen Pharmaceuticals AG在AACR 2022公布其差异化的PARP和DHODH抑制剂项目的数据

2022-10-29

chentianping (审核中...)

前往app查看评论内容

#pharma#

Front Pharmacol：四妙勇安汤治疗糖尿病视网膜病变的网络药理学与体内结合研究

2022-07-02

chentianping (审核中...)

前往app查看评论内容

#pharma#

PCI Pharma Services继收购LSNE之后继续利用先进设备扩大无菌灌封专长

2022-08-05

chentianping (审核中...)

前往app查看评论内容

#pharma#

Clin Pharmacol Ther：血管紧张素转换酶抑制剂与胰岛素促泌剂同时使用与严重低血糖的风险

2023-05-03

chentianping (审核中...)

前往app查看评论内容

#pharma#

Clin Pharmacol Ther:Secukinumab治疗银屑病的创新儿科开发之路

2022-09-12

chentianping (审核中...)

前往app查看评论内容

#pharma#

Front Pharmacol：不同PCSK9抑制剂，哪个降脂力量更强？

2022-09-22

chentianping (审核中...)

前往app查看评论内容

#pharma#

Rhizen Pharmaceuticals AG宣布即将在ESMO 2022上展示其临床阶段的资产数据；Tenalisib治疗局部晚期/转移性乳腺癌和RP12146治疗多种实体瘤

2022-10-26

chentianping (审核中...)

前往app查看评论内容

#pharma#

Eur J Clin Pharmacol：DOAC剂量处方不当在≥80岁房颤患者中的发生率和预测因素分析

2022-04-01

chentianping (审核中...)

前往app查看评论内容

#pharma#

Xlear与Dr. Ferrer BioPharma合作，向用户提供更佳鼻腔卫生体验

2022-11-15

chentianping (审核中...)

前往app查看评论内容

#pharma#

Front Pharmacol：益生菌联合中药治疗溃疡性结肠炎的疗效和安全性

2022-12-17

chentianping (审核中...)

前往app查看评论内容

#pharma#

Front Pharmacol：中医药治疗阿尔茨海默病合并骨质疏松症的广阔前景

2023-03-23

chentianping (审核中...)

前往app查看评论内容

#pharma#

Front Pharmacol：祛毒散结汤诱导NF2相关前庭神经鞘瘤生长抑制和血管正常化

2023-04-30

chentianping (审核中...)

前往app查看评论内容

#pharma#

J Ethnopharmacol：清肺口服液通过Akt信号通路促进脂肪酸依赖性M1/M2巨噬细胞极化，减轻RSV诱导的肺部炎症

2023-06-09

chentianping (审核中...)

前往app查看评论内容

#pharma#

Front Pharmacol：具有伤口愈合特性的中药

2022-10-10

chentianping (审核中...)

前往app查看评论内容

#pharma#

Skin Pharmacol Physiol：壳聚糖凝胶可有效减少皮肤出油

2022-06-17

chentianping (审核中...)

前往app查看评论内容

#pharma#

J Ethnopharmacol：清热中药注射剂治疗AECOPD疗效比较

2023-02-25

科室
- - 订阅+
  - 更多科室
工具
服务